Olena Shkondina

Olena Shkondina

Auto-generated profile, based on publicly available information

Olena Shkondina

Vinnytsya Pirogov Memorial Medical University

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2024 in Fitoterapia
Verified
Journal Article
Closed access
LBLiliia Budniak
Liliia Budniak
LSLiudmyla Slobodianiuk
Liudmyla Slobodianiuk
RKRoman Kotsyuba
Roman Kotsyuba
OAOleksandra Alchuk
Oleksandra Alchuk
OSOlena Shkondina
Olena Shkondina
SCSvitlana Chernetska
Svitlana Chernetska

1 January 2024 in Fitoterapia
Verified
Journal Article
Closed access
LBLiliia Budniak
Liliia Budniak
MSMarina Sytnyk
Marina Sytnyk
LSLiudmyla Slobodianiuk
Liudmyla Slobodianiuk
SMSvitlana Marchyshyn
Svitlana Marchyshyn
OAOleksandra Alchuk
Oleksandra Alchuk
ITIhor Tverdokhlib
Ihor Tverdokhlib

16 July 2025 in Neonatology, surgery and perinatal medicine
Verified
Journal Article
Open access
PDF file
ККК. Калько
К. Калько
OSO. Shkondina
O. Shkondina
MHM. Hainiuk
M. Hainiuk
MSM. Savokhina
M. Savokhina
MZM. Zarichkova
M. Zarichkova
ОШО. Шпичак
О. Шпичак
Pharmaceutical counselling represents a critical component of effective pharmacy practice, particularly for lifestyle medications such as combined oral contraceptives (COCs). The development of optimized pharmaceutical care approaches for COC dispensing remains both relevant and necessary for the Ukrainian pharmaceutical sector. The aim of this study was to analyse COC pharmacological safety profiles, examine co-administration considerations with other medications, and establish evidence-based pharmaceutical counselling protocols for community pharmacy settings. Materials and methods of the study. We conducted a systematic literature analysis using the PubMed database with the following search parameters: combined oral contraceptives, effectiveness, safety, contraindications, drug interactions, and pharmaceutical care. The search was limited to publications from 2016 to 2025 in Ukrainian, English, and Norwegian languages. Results and discussion. The most frequently reported adverse effects of COCs include headache, nausea, dizziness, and breast tenderness, while more severe complications such as arterial or venous thromboembolism occur less commonly. Current research inadequately addresses the long-term risks associated with COC use, particularly concerning metabolic alterations and disruptions to the body's endogenous environment. Of specific concern are the potential impacts on gut microbiota composition and subsequent psychological manifestations, which may develop with prolonged COC use in reproductive-aged women. Special consideration must be given to concomitant administration of COCs with psychotropic medications, given their typically chronic usage patterns Conclusions. These findings provide a foundation for developing standardized pharmaceutical counselling protocols for COC dispensing in community pharmacy practice.